References
- Russell RI. Protective Effccts of the Prostaglandins on the Gastric Mucosa. Amer J Med. 1986, 81 (suppl 2a): 2–4.
- Robert A. Cytoprotcction by prostaglandins. Gastroenterology. 1979, 77: 761–67.
- Konturck SJ. Action of nonsteroid antiinflammatory compounds on gastric mucosal integrity and prostaglandin formation in healthy subjects and peptic ulcer patients. Adv inflammation Res. 1984, 6: 29–37.
- Soil AH, Whittle BJR: Prostacyclin analogues inhibit canine parietal cell activity and cyclic AMP formation. Prostaglandins. 1981, 21: 353–65.
- Flemstrom G. Gastroduodcnal Mucosal Secretion of Bicarbonate and Mucus. Amer J Med. 1986, 81 (Suppl 2a) 19–22.
- Rachmilewitz D., Chapman JW, Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimctidine in treatment of gastric ulccr in outpatients. Dig Dis Sc. 1986, 31 (Suppl.): 75–80.
- Agrawal NM, Saffouri B, Kruss DM, Callison DA, Dajani EZ. Healing of benign gastric ulcer: a placebo controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E,. Dig Dis Sc. 1985, 30 (Suppl): 164–70.
- Sontag SJ, Mazure PA, Pontes JF, Bekcr SG, Dajani EZ. Misoprostol in the treatment of duodenal ulccr: a multicentcr double-blind, placebo controlled study. Dig Dis Sc. 1985, 30 (Suppl): 159–63.
- Brand DL, Roufail WM, Thomson ABR. Tapper FJ. Misoprostol, a synthetic PGE, analog, in the treatment of duodenal ulcers: a multicenter double-blind study. Dig Dis Sc. 1985, 30 (Suppl): 147–58.
- Lam SK, Lau WY. Choi EK, et al. Prostaglandin E, (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulccr healing. Dig Dis Sc. 1986, 31 (Suppl): 68–74.
- Bright-Asare P, Sontag SJ, Gould RJ. Brand DL, Roufail WM. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulccr: a multicenter doubleblind controlled trial. Dig Dis Sc. 1986, 31 (Suppl): 63–67.
- Nicholson PA. A multicenter international controlled comparison of two dosage regimens of misoprostol and cimetidine in the treatment of duodenal ulccr in outpatients. Dig Dis Sc. 1985, 30 (Suppl): 171–77.
- Herting RL, Nisscn CH. Overview of Misoprostol Clinical Experience. Dig Dis Sc. 1986, 31 (Suppl.): 47–54.
- Agrawal N, Godiwala T, Arimura A, Dajani E. Cytoprotcction by a synthetic prostaglandin against ethanol-induced gastric mucosal damage: a double-blind endoscopic study in human subjects. Gastrointestinal Endoscopy. 1986, 32: 67–70.
- Lewis J. FDA GI Advisory Committee Summary. Amer J Gastroenter. 1985, 80: 743–45.
References
- Tellier P, Voisin C. Bismesilate d’almitrine: deductions ct espoirs therapeutiques. La Presse Med. 1984, 13: 2099–2103.
- Lockhart A. Pharmacological Properties of Almitrine Bismcsylatc. Eur J Respir Dis. 1983, 64 (Suppl 126): 225–231.
- Melot C, Naeije R. Rothschild T, Mertens P, Mols P, Hallemans R. Improvement in vcntilation-perfusion matching by almitrine in COPD. Chest 1983, 83: 528–33.
- Paramelle, B, Levy P, Pirotte C. Long term follow-up of pulmonary arterial pressure evolution in COPD patients treated by almitrine bismesylate. Eur J Respir Dis. 1983, 64 (Suppl 126): 333–36.
- Bromet N, Singlas E. Pharmacocinetique clinique du hismesilate d’almitrine. La Presse Med. 1984, 13: 2071–2077.
- MacLeod CM, Thomas RW, Bartley EA, Parkhurst GW, Bachand RT Jr. Effects and handling of almitrine bismesylate in healthy subjects. Eur J Respir Dis. 1983, (Suppl 126): 275–89.
- Bell RC, Mullins RC, West LG, Bachand RT, Johanson WG Jr. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. Ann Int Med. 1986, 105: 342–46.
- Stradling JR, Nicholl CG, Cover D, Davies EE, Hughes JMB, Pride NB. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease. Eur J Respir Dis. 1983, 64 (Suppl 126): 255–64.
- Yernault JC, van Muylen A. Noseda, Ravez P, Paiva M. Effects of almitrine bismesylate in patients with COLD. Eur J Resp Dis 1983, 64 (Suppl 126): 265–70.
- Gherardi R, Benvenuti C, Lejonc JL, Louarn F, Perrier M, Schaeffcr A. Peripheral neuropathy in patients treated with almitrine dimesylate. Lancet. 1985, 1, 1247–49.
- Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980, 93: 39198.